Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
Withdrawn
Azidus Brasil
Phase 3
2010-11-01
Considering the pathogenesis of several allergic skin diseases to be investigated in this
study as well as the pharmacodynamic mechanisms of the association of dexamethasone and
clemastine fumarate, it is believed that the components of topical medication may act
synergistically in the reduction of signs and symptoms of the diseases in question. Therefore
it is expected that the association promotes results significantly superior to dexamethasone
alone.
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
Unknown status
Azidus Brasil
Phase 3
2011-03-01
The aim of this study is to prove the efficacy of the dexamethasone 0.5 mg + 1 mg clemastine
fumarate tablet compared to 0.5 mg of dexamethasone in reducing the signs and symptoms of
allergic dermatitis.
Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment
Completed
EMS
Phase 3
2012-09-06
Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and
impaired quality of life due specially pruritus and physical visible skin lesions. The
propose of this trial is evaluate the effectiveness of clemastine fumarate 1, 0 mg/g +
dexamethasone 0, 5 mg/g compared to dexchlorpheniramine maleate 10 mg/g in eczema treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
